232 related articles for article (PubMed ID: 19464192)
1. Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo.
Thomas N; Bechet D; Becuwe P; Tirand L; Vanderesse R; Frochot C; Guillemin F; Barberi-Heyob M
J Photochem Photobiol B; 2009 Aug; 96(2):101-8. PubMed ID: 19464192
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties.
Thomas N; Pernot M; Vanderesse R; Becuwe P; Kamarulzaman E; Da Silva D; François A; Frochot C; Guillemin F; Barberi-Heyob M
Biochem Pharmacol; 2010 Jul; 80(2):226-35. PubMed ID: 20380812
[TBL] [Abstract][Full Text] [Related]
3. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice.
Thomas N; Tirand L; Chatelut E; Plénat F; Frochot C; Dodeller M; Guillemin F; Barberi-Heyob M
Photochem Photobiol Sci; 2008 Apr; 7(4):433-41. PubMed ID: 18385885
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study.
Tirand L; Thomas N; Dodeller M; Dumas D; Frochot C; Maunit B; Guillemin F; Barberi-Heyob M
Drug Metab Dispos; 2007 May; 35(5):806-13. PubMed ID: 17283031
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
7. New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy.
Kamarulzaman EE; Gazzali AM; Acherar S; Frochot C; Barberi-Heyob M; Boura C; Chaimbault P; Sibille E; Wahab HA; Vanderesse R
Int J Mol Sci; 2015 Oct; 16(10):24059-80. PubMed ID: 26473840
[TBL] [Abstract][Full Text] [Related]
8. Response surface methodology: an extensive potential to optimize in vivo photodynamic therapy conditions.
Tirand L; Bastogne T; Bechet D; Linder M; Thomas N; Frochot C; Guillemin F; Barberi-Heyob M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):244-52. PubMed ID: 19604651
[TBL] [Abstract][Full Text] [Related]
9. Studies on preparation and photodynamic mechanism of chlorin P6-13,15-N-(cyclohexyl)cycloimide (Chlorin-H) and its antitumor effect for photodynamic therapy in vitro and in vivo.
Yan YJ; Zheng MZ; Chen ZL; Yu XH; Yang XX; Ding ZL; Xu L
Bioorg Med Chem; 2010 Sep; 18(17):6282-91. PubMed ID: 20691601
[TBL] [Abstract][Full Text] [Related]
10. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.
Frochot C; Di Stasio B; Vanderesse R; Belgy MJ; Dodeller M; Guillemin F; Viriot ML; Barberi-Heyob M
Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161
[TBL] [Abstract][Full Text] [Related]
11. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
[TBL] [Abstract][Full Text] [Related]
12. L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells.
Stoeck A; Schlich S; Issa Y; Gschwend V; Wenger T; Herr I; Marmé A; Bourbie S; Altevogt P; Gutwein P
Cancer Lett; 2006 Aug; 239(2):212-26. PubMed ID: 16377081
[TBL] [Abstract][Full Text] [Related]
13. Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium.
Hess AP; Schanz A; Baston-Buest DM; Hirchenhain J; Stoff-Khalili MA; Bielfeld P; Kruessel JS
J Reprod Immunol; 2009 Jan; 79(2):129-36. PubMed ID: 18996601
[TBL] [Abstract][Full Text] [Related]
14. Functionalized silica-based nanoparticles for photodynamic therapy.
Couleaud P; Bechet D; Vanderesse R; Barberi-Heyob M; Faure AC; Roux S; Tillement O; Porhel S; Guillemin F; Frochot C
Nanomedicine (Lond); 2011 Aug; 6(6):995-1009. PubMed ID: 21726134
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.
Bechet D; Tirand L; Faivre B; Plénat F; Bonnet C; Bastogne T; Frochot C; Guillemin F; Barberi-Heyob M
Pharm Res; 2010 Mar; 27(3):468-79. PubMed ID: 20087632
[TBL] [Abstract][Full Text] [Related]
16. Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma.
Thomas E; Colombeau L; Gries M; Peterlini T; Mathieu C; Thomas N; Boura C; Frochot C; Vanderesse R; Lux F; Barberi-Heyob M; Tillement O
Int J Nanomedicine; 2017; 12():7075-7088. PubMed ID: 29026302
[TBL] [Abstract][Full Text] [Related]
17. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex.
Starzec A; Ladam P; Vassy R; Badache S; Bouchemal N; Navaza A; du Penhoat CH; Perret GY
Peptides; 2007 Dec; 28(12):2397-402. PubMed ID: 17983687
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy.
Schneider R; Schmitt F; Frochot C; Fort Y; Lourette N; Guillemin F; Müller JF; Barberi-Heyob M
Bioorg Med Chem; 2005 Apr; 13(8):2799-808. PubMed ID: 15781391
[TBL] [Abstract][Full Text] [Related]
19. Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature.
Herringson TP; Altin JG
Int J Pharm; 2011 Jun; 411(1-2):206-14. PubMed ID: 21443937
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition.
Baba T; Kariya M; Higuchi T; Mandai M; Matsumura N; Kondoh E; Miyanishi M; Fukuhara K; Takakura K; Fujii S
Gynecol Oncol; 2007 Jun; 105(3):703-11. PubMed ID: 17376520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
